These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8983908)

  • 1. [The prostate-specific antigen in the early recognition of prostate carcinoma].
    Wolff JM; Jakse G
    Dtsch Med Wochenschr; 1996 Nov; 121(48):1508-14. PubMed ID: 8983908
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical and histopathological characteristics of nonpalpable prostatic carcinoma].
    Landmann C
    Strahlenther Onkol; 1995 Mar; 171(3):174-5. PubMed ID: 7535953
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnosis of prostate cancer: comparison of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography.
    Tsui KH; Chang PL; Wang TM; Hsieh ML
    Changgeng Yi Xue Za Zhi; 1997 Mar; 20(1):23-8. PubMed ID: 9178589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Early diagnosis of cancer of the prostate. 5-year analysis].
    Sanz Velez JI; Allepuz Losa C; Gil Sanz MJ; Plaza L; Castrillo J; Cuesta Presedo JM; Rioja Sanz LA
    Actas Urol Esp; 1997 Oct; 21(9):827-34. PubMed ID: 9471865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of the absolute value and "density" of the prostate-specific antigen estimated echographically in the selection of patients to undergo a biopsy in suspected prostatic carcinoma. A comparison between PSA, palpation and echography in 95 patients undergoing echo-guided endorectal prostatic biopsy].
    Di Donna A; Bazzocchi M; Guerra UP; Bendini M; De Biasi F; Caminiti F; Delendi M
    Radiol Med; 1993; 85(1-2):84-9. PubMed ID: 7683136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Systematic biopsy with multiple samples per lobe in the diagnosis of prostatic carcinoma].
    Limitone DA; Lorusso A; Saponaro P; Marucco EC; Pagliarulo A
    Arch Ital Urol Androl; 1998 Jun; 70(3 Suppl):25-9. PubMed ID: 9707767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of transrectal ultrasound and biopsy in the detection of prostate cancer.
    Selzman AA; Resnick MI
    Tech Urol; 1995; 1(4):209-16. PubMed ID: 9118393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T3 prostate cancer: how reliable is clinical staging?
    Ravery V; Boccon-Gibod L
    Semin Urol Oncol; 1997 Nov; 15(4):202-6. PubMed ID: 9421446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and screening for prostate cancer.
    Lee F; Torp-Pedersen S; Cooner W; Drago J; Holtgrewe L; Littrup P; Resnick M
    Cancer; 1992 Jul; 70(1 Suppl):355-6. PubMed ID: 1376205
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnosing benign prostatic hyperplasia versus prostate cancer.
    Denis LJ
    Br J Urol; 1995 Jul; 76 Suppl 1():17-23. PubMed ID: 7544211
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prostatic biopsy: technic, value and complications].
    Gasman D; Abbou CC
    Ann Urol (Paris); 1995; 29(5):229-301. PubMed ID: 8638906
    [No Abstract]   [Full Text] [Related]  

  • 12. Biopsy-based diagnosis of prostate cancer in 1290 patients referred for prostate examination: results according to the PSA level, digital rectal examination and ultrasonography.
    Szabó J; Végh A; Gasman D; Hoznek A; Chopin DK; Abbou CC
    Acta Chir Hung; 1998; 37(1-2):95-100. PubMed ID: 10196617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The diagnosis of prostatic carcinoma].
    Hammerer P; Huland H
    Fortschr Med; 1991 Sep; 109(26):512-7. PubMed ID: 1723711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical utility of available diagnostic tests in prostatic carcinoma. Results of 500 biopsies. II. Rectal palpation, PSA, and transrectal echography].
    Rodríguez Rodríguez R; Mayayo Dehesa T; Galbis Sanjuan F; Jiménez Cidre M; Burgos Revilla FJ; Gómez dos Santos V; García González R
    Arch Esp Urol; 1997 May; 50(4):339-45. PubMed ID: 9313042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of ultrasound in prostate cancer detection in patients with an elevated prostate specific antigen level but no prostatic nodule.
    Sanders RC
    Md Med J; 1993 Oct; 42(10):1007-11. PubMed ID: 7505045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate specific antigen density of the transition zone for early detection of prostate cancer.
    Djavan B; Zlotta AR; Byttebier G; Shariat S; Omar M; Schulman CC; Marberger M
    J Urol; 1998 Aug; 160(2):411-8; discussion 418-9. PubMed ID: 9679889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part II: Early detection strategies.
    Coley CM; Barry MJ; Fleming C; Wasson JH; Fahs MC; Oesterling JE
    Urology; 1995 Aug; 46(2):125-41. PubMed ID: 7542817
    [No Abstract]   [Full Text] [Related]  

  • 18. Directed and random biopsies of the prostate: indications based on combined results of transrectal sonography and prostate-specific antigen density determinations.
    Olson MC; Posniak HV; Fisher SG; Flisak ME; Salomon CG; Flanigan RC; Waters WB; Pyle JM
    AJR Am J Roentgenol; 1994 Dec; 163(6):1407-11. PubMed ID: 7527614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percent free prostate-specific antigen for first-time prostate biopsy.
    Lee CT; Scardino PT
    Urology; 2001 Apr; 57(4):594-8. PubMed ID: 11306355
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostate cancer and prostate specific antigen. A Jamaican perspective.
    Douglas LL
    West Indian Med J; 1999 Jun; 48(2):47-9. PubMed ID: 10492600
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.